10 research outputs found

    Pastoralism and delay in diagnosis of TB in Ethiopia

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Tuberculosis (TB) is a major public health problem in the Horn of Africa with Ethiopia being the most affected where TB cases increase at the rate of 2.6% each year. One of the main contributing factors for this rise is increasing transmission due to large number of untreated patients, serving as reservoirs of the infection within the communities. Reduction of the time between onset of TB symptoms to diagnosis is therefore a prerequisite to bring the TB epidemic under control. The aim of this study was to measure duration of delay among pastoralist TB patients at TB management units in Somali Regional State (SRS) of Ethiopia.</p> <p>Methods</p> <p>A cross sectional study of 226 TB patients with pastoralist identity was conducted in SRS of Ethiopia from June to September 2007. Patients were interviewed using questionnaire based interview. Time between onset of TB symptoms and first visit to a professional health care provider (patient delay), and the time between first visits to the professional health care provider to the date of diagnosis (medical provider's delay) were analyzed. Both pulmonary and extrapulmonary TB patients were included in the study.</p> <p>Result</p> <p>A total of 226 pastoralist TB patients were included in this study; 93 (41.2%) were nomadic pastoralists and 133 (58.8%) were agro-pastoralists. Median patient delay was found to be 60 days with range of 10–1800 days (83 days for nomadic pastoralists and 57 days for agro-pastoralists). Median health care provider's delay was 6 days and median total delay was 70 days in this study. Patient delay constituted 86% of the total delay. In multivariate logistic regression analysis, nomadic pastoralism (aOR. 2.69, CI 1.47–4.91) and having low biomedical knowledge on TB (aOR. 2.02, CI 1.02–3.98) were significantly associated with prolonged patient delay. However, the only observed risk factor for very long patient delay >120 days was distance to health facility (aOR.4.23, CI 1.32–13.54). Extra-pulmonary TB was the only observed predictor for health care providers' delay (aOR. 3.39, CI 1.68–6.83).</p> <p>Conclusion</p> <p>Patient delay observed among pastoralist TB patients in SRS is one of the highest reported so far from developing countries, exceeding two years in some patients. This long patient delay appears to be associated with patient's inadequate knowledge of the disease and distance to health care facility with nomadic pastoralists being the most affected. Regional TB control programmes need to consider the exceptional circumstances of pastoralists, to maximise their access to TB services.</p

    The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

    Get PDF
    INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

    The european dream in the negro-african literature of french expression

    No full text
    Les Ă©pigones de la NĂ©gritude nous ont habituĂ©s, dans la confrontation de l’Afrique et l’Europe, Ă  la mise en scĂšne d’un personnage qui, aprĂšs avoir rĂȘvĂ© d’Europe avec des stĂ©rĂ©otypes de l’image de la France vĂ©hiculĂ©es par l’école coloniale, est confrontĂ©, lors de son sĂ©jour en Europe, aux conditions de l’exil avec l’éloignement de la terre maternelle Ă  laquelle porte toutes ses aspirations. Mais avec les Ă©crivains de la Migritude, l’émigration vers l’Europe prend un contour diffĂ©rent, elle n’est plus motivĂ©e par une volontĂ© de dĂ©couverte mais une fuite de la terre maternelle devenue rĂ©pulsive alors que l’Europe est aux yeux du migrant un lieu attractif enjolivĂ© par les rĂ©cits des immigrĂ©s qui ont dĂ©jĂ  fait le voyage. Ce prĂ©sent travail de recherche s’efforce de rendre compte de l’évolution qui s’est opĂ©rĂ©e sur la reprĂ©sentation de l’immigration en Europe depuis les Ă©crivains de la premiĂšre gĂ©nĂ©ration jusqu’à ceux de la seconde.The followers of the Negritude accustomed us to the confrontation between Africa and Europe through the staging of a character-dreaming of Europe with stereotyped images of France conveyed by the colonial school-who is confronted with the conditions of exile during his stay in Europe and the remoteness of motherland which bears all his aspirations. But for the writers of Migritude, emigration to Europe takes a different turn; it is no longer motivated by a desire for discovery but an escape from the native land which has become repulsive, while Europe is in the eyes of migrants, an attractive place embellished by the stories of immigrants who, have already made the journey. The present research seeks to reflect on the change that has taken place on the representation of immigration in Europe, from the writers of the first generation to those of the second generation

    Le rĂȘve europĂ©en dans la littĂ©rature nĂ©gro-africaine d'expression française

    No full text
    The followers of the Negritude accustomed us to the confrontation between Africa and Europe through the staging of a character-dreaming of Europe with stereotyped images of France conveyed by the colonial school-who is confronted with the conditions of exile during his stay in Europe and the remoteness of motherland which bears all his aspirations. But for the writers of Migritude, emigration to Europe takes a different turn; it is no longer motivated by a desire for discovery but an escape from the native land which has become repulsive, while Europe is in the eyes of migrants, an attractive place embellished by the stories of immigrants who, have already made the journey. The present research seeks to reflect on the change that has taken place on the representation of immigration in Europe, from the writers of the first generation to those of the second generation.Les Ă©pigones de la NĂ©gritude nous ont habituĂ©s, dans la confrontation de l’Afrique et l’Europe, Ă  la mise en scĂšne d’un personnage qui, aprĂšs avoir rĂȘvĂ© d’Europe avec des stĂ©rĂ©otypes de l’image de la France vĂ©hiculĂ©es par l’école coloniale, est confrontĂ©, lors de son sĂ©jour en Europe, aux conditions de l’exil avec l’éloignement de la terre maternelle Ă  laquelle porte toutes ses aspirations. Mais avec les Ă©crivains de la Migritude, l’émigration vers l’Europe prend un contour diffĂ©rent, elle n’est plus motivĂ©e par une volontĂ© de dĂ©couverte mais une fuite de la terre maternelle devenue rĂ©pulsive alors que l’Europe est aux yeux du migrant un lieu attractif enjolivĂ© par les rĂ©cits des immigrĂ©s qui ont dĂ©jĂ  fait le voyage. Ce prĂ©sent travail de recherche s’efforce de rendre compte de l’évolution qui s’est opĂ©rĂ©e sur la reprĂ©sentation de l’immigration en Europe depuis les Ă©crivains de la premiĂšre gĂ©nĂ©ration jusqu’à ceux de la seconde

    MĂ©thodologie pour l’implĂ©mentation du recensement national du cheptel animal en RĂ©publique de Djibouti

    No full text
    La Direction de la Statistique et des Études DĂ©mographiques (DISED) et la Direction de l’Élevage et des Services VĂ©tĂ©rinaires (DESV) avec l’appui technique de la FAO Ă  Djibouti (Ă  travers le TCP/DJI/3501) ont dĂ©veloppĂ© d’une façon  participative une mĂ©thodologie pour le recensement du cheptel animal en RĂ©publique de Djibouti. Cette mĂ©thodologie a Ă©tĂ© Ă©laborĂ©e en prenant en compte les avis des leaders d’opinion clĂ©s et des experts techniques locaux ainsi que la documentation scientifique existante dans ce domaine.La mĂ©thodologie propose l’utilisation du relevĂ© aĂ©rien pour l’identification des emplacements des mĂ©nages Ă©leveurs et l’estimation de leurs effectifs ainsi que de la taille et de la composition de leurs troupeaux en fournissant les coordonnĂ©es GPS. Le relevĂ© aĂ©rien permettra Ă©galement d’identifier et de fournir les coordonnĂ©es gĂ©ographiques de tous les points d’eau. L’agent recenseur va interviewer le chefde mĂ©nage de chaque exploitation d’élevage identifiĂ©e. La technique « boule de neige » sera utilisĂ©e pour accĂ©lĂ©rer l’identification des mĂ©nages Ă©leveurs.Mots-clĂ©s: mĂ©thodologie, recensement du bĂ©tail Djibout

    Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries

    No full text
    Background: Pancreatic surgery remains associated with high morbidity rates. Although postoperative mortality appears to have improved with specialization, the outcomes reported in the literature reflect the activity of highly specialized centres. The aim of this study was to evaluate the outcomes following pancreatic surgery worldwide.Methods: This was an international, prospective, multicentre, cross-sectional snapshot study of consecutive patients undergoing pancreatic operations worldwide in a 3-month interval in 2021. The primary outcome was postoperative mortality within 90 days of surgery. Multivariable logistic regression was used to explore relationships with Human Development Index (HDI) and other parameters.Results: A total of 4223 patients from 67 countries were analysed. A complication of any severity was detected in 68.7 percent of patients (2901 of 4223). Major complication rates (Clavien-Dindo grade at least IIIa) were 24, 18, and 27 percent, and mortality rates were 10, 5, and 5 per cent in low-to-middle-, high-, and very high-HDI countries respectively. The 90-day postoperative mortality rate was 5.4 per cent (229 of 4223) overall, but was significantly higher in the low-to-middle-HDI group (adjusted OR 2.88, 95 per cent c.i. 1.80 to 4.48). The overall failure-to-rescue rate was 21 percent; however, it was 41 per cent in low-to-middle-compared with 19 per cent in very high-HDI countries.Conclusion: Excess mortality in low-to-middle-HDI countries could be attributable to failure to rescue of patients from severe complications. The authors call for a collaborative response from international and regional associations of pancreatic surgeons to address management related to death from postoperative complications to tackle the global disparities in the outcomes of pancreatic surgery (NCT04652271; ISRCTN95140761)

    Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    Get PDF
    Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P &lt; 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)

    Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

    No full text
    International audienc
    corecore